Alena Gros
Alena received her Ph.D. from the University of Barcelona, Spain. Following that, Alena joined Dr. Steven Rosenberg’s group at the National Institutes of Health, NCI, where she stayed for 7 years. Her work at the NCI led to the identification of biomarkers that can guide the detection and isolation of tumor-reactive and mutation-specific T cells from the tumor and peripheral blood of cancer patients. These findings may have important implications for making T-cell based immunotherapies more widely available. Alena joined the Cancer Immunotherapy Program at VHIO in October 2016. At VHIO her group’s research focuses on studying the naturally-occurring T-cell responses against cancer. The main goal of the Tumor Immunology and Immunotherapy group is to better understand current immunotherapies and to design more effective, personalized, cancer immunotherapies.
http://www.vhio.net/en/tumor-immunology-immunotherapy-group/